Results 1 to 10 of about 219,576 (296)
Marine Algae as a Potential Source for Anti-Obesity Agents [PDF]
Marine Drugs, 2016 Obesity is a major epidemic that poses a worldwide threat to human health, as it is also associated with metabolic syndrome, type 2 diabetes and cardiovascular disease. Therapeutic intervention through weight loss drugs, accompanied by diet and exercise,
Chu Wan-Loy, Phang Siew-Moi
doaj +8 more sources
Bulletin of Faculty of Pharmacy Cairo University, 2014 Obesity is a complex disease caused by the interaction of a myriad of genetic, dietary, lifestyle, and environmental factors, which favors a chronic positive energy balance, and leads to increased body fat mass.
Gamal A. Mohamed +3 more
doaj +3 more sources
Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management [PDF]
Frontiers in Pharmacology, 2023 Obesity affects more than 10% of the adult population globally. Despite the introduction of diverse medications aimed at combating fat accumulation and obesity, a significant number of these pharmaceutical interventions are linked to substantial ...
Ummul Fathima Shaik Mohamed Sayed +18 more
doaj +4 more sources
Screening of Anti-Obesity Agent from Herbal Mixtures [PDF]
Molecules, 2012 Globally, one in three of the World’s adults are overweight and one in 10 is obese. By 2015, World Health Organization (WHO) estimates the number of chubby adults will balloon to 2.3 billion—Equal to the combined populations of China, Europe and the ...
Sung-Kee Jo, Uhee Jung, Changhyun Roh
doaj +3 more sources
PLoS ONE, 2018 ObjectivesWe sought to evaluate the association between obesity and response to anti-tumor necrosis factor-α (TNF) agents, through a systematic review and meta-analysis.MethodsThrough a systematic search through January 24, 2017, we identified randomized
Siddharth Singh +8 more
doaj +3 more sources
Efficacy of anti-obesity agents: a systematic review and network meta-analysis of randomized controlled trials [PDF]
Perspectives In Medical Research, 2023 Background: To conduct a network meta-analysis comparing the safety and efficacy of five anti-obesity drugs approved by the United States Food and Drug Administration (US FDA)-Bupropion/Naltrexone combination (BUP/NLX), Liraglutide (LIRA), Orlistat (ORLI)
Nishant Babubhai Prajapati +3 more
doaj +1 more source
Journal of Obesity & Metabolic Syndrome, 2021 There is a new generation of antiobesity drugs in development or just arriving on the scene. First, setmelanotide has been approved for three of the ultrarare genetic conditions that cause obesity–#8211;pro-opiomelanocortin deficiency, proprotein ...
Donna H. Ryan
doaj +1 more source
Anti-Obesity Drugs: A Review about Their Effects and Safety [PDF]
Diabetes & Metabolism Journal, 2012 The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended.
Jun Goo Kang, Cheol-Young Park
doaj +1 more source
iScience, 2023 Summary: We describe the therapeutic journey of a 33-year-old patient with early-onset obesity (BMI 56.7 kg/m2) and hyperphagia due to a likely pathogenic heterozygous melanocortin-4 receptor (MC4R) gene variant.She was unsuccessfully treated with ...
Mila S. Welling +6 more
doaj +1 more source
Encapsulated Peptides and Proteins with an Effect on Satiety
Nanomaterials, 2023 The world scenario has undergone a nutritional transition in which some countries have left the reality of malnutrition and now face an epidemic of excess body weight. Researchers have been looking for strategies to reverse this situation.
Rafael O. de A. Costa +4 more
doaj +1 more source